CLEVELAND, June 30, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today announced that it has agreed to acquire Curtis Instruments, Inc. from Rehlko, for approximately $1 billion in cash. The transaction is subject to customary closing conditions, including receipt of applicable regulatory approvals, and is expected to close by the end of calendar year 2025. "Rehlko is proud of the legacy and performance of Curtis as a high-performing, ...

NASDAQ: DSGR 15th Annual East Coast IDEAS Conference June 12, 2025 Disclaimers Cautionary Note Regarding Forward-Looking Statements This presentation contains certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the "safe-harbor" provisions under the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. The terms "aim," "anticipate," "believe," "c ...

Product line includes Druck, Panametrics and Reuter-Stokes brandsTransaction aligns with Baker Hughes’ ongoing portfolio optimization HOUSTON and LONDON, June 09, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Monday an agreement to sell its Precision Sensors & Instrumentation (PSI) product line to Crane Company (NYSE: CR, “Crane”), a diversified manufacturer of engineered industrial products, for a total cash consideration of approximately $1.15 billion. PSI, p ...

Bio-Techne (TECH) FY Conference June 03, 2025 03:40 PM ET Speaker0 Thanks everyone for hanging with us towards the end of the day here. And thanks for joining us for the Biotechnology Management Presentation. My name is Matt Larue. Very happy to have CEO Kim Kelderman here and Dave Claire from IR is here as well. So thanks to them for joining us. I have two logistical comments. One, the breakout is in Maher on the Second Floor. And then second, for a list of our research disclosures and conflicts of interes ...

PARIS, France, May 22, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced a long-term contract renewal and extension with bioMérieux, a world leader in the field of In Vitro Diagnostics providing solutions to improve patient health and to ensure consumer safety. “We are delighted that bioMérieux, our partner for over 20 years, renewed the trust they place in GXO. Following a successful overhaul of the distribution of the Reage ...

STERIS' (STE) new acquisitions and partnerships strengthen its product offerings. The stock carries a Zacks Rank #2 (Buy) currently.Factors Driving STERIS' GrowthSTERIS’ Healthcare segment is gaining from the successful market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. Further, its services to maintain that equipment, repair reusable procedural instruments and outsource instrument reprocessing services are gaining traction. For the fourth quart ...

Core Insights - Elbit Systems reported strong financial results for Q1 2025, with revenues of $1.9 billion, a 22% increase from Q1 2024, and a GAAP net income of $107.1 million, reflecting a significant growth trend in the defense sector due to increased global demand [1][3][10]. Financial Performance - Revenues for Q1 2025 were $1,895.8 million, compared to $1,554.0 million in Q1 2024, marking a 22% increase [4]. - GAAP gross profit was $454.3 million (24.0% of revenues) in Q1 2025, slightly down from $374.1 million (24.1% of revenues) in Q1 2024 [6]. - Non-GAAP gross profit for Q1 2025 was $460.6 million (24.3% of revenues), compared to $383.4 million (24.7% of revenues) in Q1 2024 [6]. - GAAP operating income increased to $149.7 million (7.9% of revenues) in Q1 2025 from $105.4 million (6.8% of revenues) in Q1 2024 [8]. - Non-GAAP operating income rose to $165.1 million (8.7% of revenues) in Q1 2025, up from $121.6 million (7.8% of revenues) in Q1 2024 [8]. - GAAP net income attributable to shareholders was $107.1 million (5.6% of revenues) in Q1 2025, compared to $73.7 million (4.7% of revenues) in Q1 2024 [10]. - Non-GAAP net income attributable to shareholders was $117.2 million (6.2% of revenues) in Q1 2025, up from $80.7 million (5.2% of revenues) in Q1 2024 [10]. - GAAP diluted earnings per share were $2.35 in Q1 2025, compared to $1.65 in Q1 2024 [11]. Order Backlog and Cash Flow - The order backlog as of March 31, 2025, totaled $23.1 billion, a 14% increase from Q1 2024 [12]. - Free cash flow generated during the quarter was $161 million [3]. - Cash flow from operating activities was $183.6 million in Q1 2025, compared to cash flow used in operating activities of $6.4 million in Q1 2024 [13]. Segment Performance - Aerospace revenues increased by 20% in Q1 2025, driven by higher Precision Guided Munition sales [5]. - C4I and Cyber revenues grew by 12%, primarily due to sales of radio systems and command and control systems [5]. - Land revenues surged by 48%, attributed to ammunition and munition sales [5]. - Elbit Systems of America revenues rose by 18%, reflecting increased sales in Warfighters systems and medical instrumentation [5]. Market Context - The ongoing "Swords of Iron" war has led to a material increase in demand for Elbit Systems' products from the Israel Ministry of Defense [13][14]. - The company is well-positioned to benefit from increasing defense budgets globally, particularly in Europe [3]. Dividend Declaration - The Board of Directors declared a dividend of $0.60 per share, with a record date of June 24, 2025, and payment scheduled for July 7, 2025 [18].

Bio-Techne (TECH) 2025 Conference May 13, 2025 01:40 PM ET Speaker0 Fireside Chat. I'm joined by Kim Kelderman, Chief Executive Officer and Jim Hipple, Chief Financial Officer. Gentlemen, thanks for being here. Thanks for having us. Format is going to be a fireside chat, and then we'll open up to the audience. If there's any questions, just raise your hand and we can squeeze you in as well. I guess just to kick things off, you reported fiscal 3Q results recently, solid results, especially considering some o ...

RESTON, Va., May 13, 2025 /PRNewswire/ -- V2X Inc. (NYSE: VVX) has been selected as an awardee on the U.S. Army's Live Training, Ranges, and Combat Training Centers (LTRaC) Indefinite Delivery, Indefinite Quantity (IDIQ) Multiple Award Contract 3. This strategic contract, supporting the U.S. Army Program Executive Office for Simulation, Training and Instrumentation (PEO STRI), delivers life-cycle product line management, engineering, and manufacturing for both existing and new training instrumentation syste ...

Q1 2025 EARNINGS CONFERENCE CALL Conference Call Dial-in numbers: (800) 343-5172 (domestic) (203) 518-9856 (international) Conference code: CWQ125 May 8, 2025 1 Investor Day 2024 SAFE HARBOR STATEMENT Please note that the information provided in this presentation is accurate as of the date of the original presentation. The presentation will remain posted on this website from one to twelve months following the initial presentation, but content will not be updated to reflect new information that may become av ...